Pyxis Oncology Inc
Pyxis Oncology Inc (PYXS) Historical Volatility
PYXS 30-day historical volatility is 111%. This ranks in the 40th percentile of readings over the past year.
Read more
Tracking PYXS historical volatility helps you see how much Pyxis Oncology Inc's stock price has actually moved over past periods, giving you a baseline to judge whether current option premiums are fair, cheap, or expensive. While implied volatility tells you what the market expects, Pyxis Oncology Inc's HV tells you what really happened. Use our scanner to monitor PYXS 30 day historical volatility alongside longer lookback windows and spot the moments when realized and implied diverge.
Historical volatility is the annualized standard deviation of an underlying's past returns, typically measured over rolling windows like 10, 20, 30, or 60 days. The PYXS 30 day historical volatility is one of the most widely watched readings because it balances responsiveness with stability. Comparing Pyxis Oncology Inc's HV to its implied volatility reveals the volatility risk premium — when IV sits well above HV, option sellers tend to have an edge; when HV runs hot relative to IV, buyers may be underpaying for movement.
Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, non-small cell lung cancer (NSCLC), and other solid tumors; and PYX-102, an investigational immune-therapeutic for treatment of solid tumors. The company's antibody drug conjugate (ADC) product candidates comprise of PYX-201, an investigational novel ADC to treat NSCLC, breast cancer, and other solid tumors; PYX-202, an investigational novel ADC for treatment of SCLC, soft tissue sarcoma, and other solid tumors; and PYX-203, an investigational ADC for the treatment of acute myeloid leukemia and myeloid dysplastic syndrome.
The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.
Sizing a long premium trade, modeling a covered call, or hunting volatility arbitrage all come back to one question: how much has the stock actually moved? Our scanner puts Pyxis Oncology Inc's historical volatility side-by-side with implied readings across every lookback window, so you can see exactly where PYXS HV is running hot, cold, or in line. Make the PYXS 30 day historical volatility — and every other window — work for your edge instead of against it.
As of September 29, 2026
As of September 29, 2026
See how volatility has moved over time
Track PYXS historical volatility, spot where IV and realized volatility diverge, and find options that are priced in your favor right now.
Start your 14-day free trial→